英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
YO-01027
|
209984-56-5 |
YO127
|
YO01027;N-[(1S)-2-[[(7S)-6,7-二氢-5-甲基-6-氧代-5H-二苯并[B,D]氮杂卓-7-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟苯乙酰胺;Γ-分泌酶抑制剂;YO-01027-分泌酶抑制剂;二苯并氮卓,Γ-SECRETASE 抑制剂;二苯并氮卓;CS-366;YO-01027;YO01027;DIBENZAZEPINE;DESHYDROXY LY 411575;DBZ
|
C26H23F2N3O3 |
463.49 | |
I-BRD9
|
1714146-59-4 |
GSK62
|
I-BRD9;I-brd9 GSK602;N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)-5-ethyl-4-oxo-7-(3-(trifluoromethyl)phenyl)-4,5-di;5-Ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyridine-2-carboximidamide
|
|||
BAY 41-2272
|
256376-24-6 |
湾41-2272
|
BAY 41-2272;256376-24-6;UNII-34A162J6WB;IN1523;BAY-41-2272;3-(4-AMINO-5-CYCLOPROPYLPYRIMIDIN-2-YL)-1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3;4-B]PYRIDINE
|
C20H17FN6 |
360.394 | |
UNC1999
|
1431612-23-5 |
UNC1999
|
CS-999;N-[(1,2-二氢-6-甲基-2-氧代-4-丙基-3-吡啶基)甲基]-1-(1-甲基乙基)-6-[6-[4-(1-甲基乙基)-1-哌嗪基]-3-吡啶基]-1H-吲唑-4-甲酰胺;UNC1999;UNC 1999;UNC1999;UNC-1999;UNC 1999;N-[(6-METHYL-2-OXO-4-PROPYL-1H-PYRIDIN-3-YL)METHYL]-1-PROPAN-2-YL-6-[6-(4-PROPAN-2-YLPIPERAZIN-1-YL)PYRIDIN-3-YL]INDAZOLE-4-CARBOXAMIDE
|
C33H43N7O2 |
569.74022 | |
GSK343
|
1346704-33-3 |
GSK343
|
1-异丙基-N-[(6-甲基-2-氧代-4-丙基-1,2-二氢-3-吡啶基)甲基]-6-[2-(4-甲基-1-哌嗪基)-4-吡啶基]-1H-吲唑-4-甲酰胺;1-异丙基-N-[(6-甲基-2-氧代-4-丙基-1;GSK343;GSK 343;GSK-343;CS-728;2-二氢-3-吡啶基)甲基]-6-[2-(4-甲基-1-哌嗪基)-4-吡啶基]-1H-吲唑-4-甲酰胺;N-[(6-METHYL-2-OXO-4-PROPYL-1H-PYRIDIN-3-YL)METHYL]-6-[2-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-4-YL]-1-PROPAN-2-YLINDAZOLE-4-CARBOXAMIDE
|
C31H39N7O2 |
541.68706 | |
Perifosine
|
157716-52-4 |
Perifosine (KRX-41)
|
KRX-0401;NSC 639966;D-21266;KRX 0401;KRX0401;D21266;D 21266;(1,1-二甲基哌啶-1-4-基)十八烷基磷酸酯 (KRX-0401);(1,1-二甲基哌啶-1-4-基)十八烷基磷酸酯;哌立福新(KRX-0401);派立福新;哌立福新,一种AKT 抑制剂;KRX0401;KRX 0402
|
C25H52NO4P |
461.663 | 690-653-3 |
H-PHE-ASN-ALA-PRO-PHE-ASP-VAL-GLY-ILE-LYS-LEU-SER-GLY-VAL-GLN-TYR-GLN-GLN-HIS-SER-GLN-ALA-LEU-NH2
|
1081110-72-6 |
OBESTATIN (HUMAN)
|
H-PHE-ASN-ALA-PRO-PHE-ASP-VAL-GLY-ILE-LYS-LEU-SER-GLY-VAL-GLN-TYR-GLN-GLN-HIS-SER-GLN-ALA-LEU-NH2;OBESTATIN (HUMAN);FNAPFDVGIKLSGVQYQQHSQAL-NH2
|
|||
Arm-390Hcl
|
209808-47-9 |
ARM-39HCL
|
ARM 390;ARM-390;ARM390
|
C23H29ClN2O |
384.94216 | |
5-Carboxytetramethylrhodamine succinimidyl ester
|
150810-68-7 |
5-羧基四甲基罗丹明琥珀酰亚胺酯
|
5-羧基四甲基罗丹明琥珀酰亚胺酯;CS-2126;5-羧基四甲基罗丹明琥珀酰亚胺脂;5-羧基四甲基罗丹明琥珀酰亚胺酯(单一化合物);5-TAMRA,SE [5-羧基四甲基罗丹明琥珀酰亚胺酯];5-TAMRA,SE>95%
|
C29H25N3O7 |
527.52 | |
broxuridine
|
59-14-3 |
溴脲苷
|
溴尿苷;1-(2-脱氧-Β-D-呋喃核糖基)-5-溴尿嘧啶;5-溴-2'-脱氧尿苷,5-BROMO-2'-DEOXYURIDINE;脱氧溴尿苷,BROMODEOXYURIDINE;溴苷;溴尿嘧啶脱氧核苷,5-BROMOURACIL DEOXYRIBOSIDE;5-溴-2'-脱氧尿苷,99%;5-溴-2'-脱氧尿苷;6-溴去氧脲苷
|
C9H11BrN2O5 |
307.1 | 200-415-9 |
2-[Tris(hydroxymethyl)methylamino]-1-ethanesulfonic acid
|
7365-44-8 |
2-[[三(羟甲基)甲基]氨基]乙磺酸
|
TES 缓冲液;2-[Tris(hydroxymethyl)methylamino]-1-ethanesulfonic acid (TES),超纯级,≥ 99.5%(T);TRIS乙磺酸,≥ 99.5%(T);N-三(羟甲基)甲基-2-氨基乙烷磺酸;3-[(羟甲基)甲基胺]乙烷磺酸;2-[[三(羟甲基)甲基]氨基]乙磺酸;2-[(三(羟甲基)甲基)氨基]-1-乙磺酸;Tris乙磺酸(TES)
|
C6H15NO6S |
229.25 | 230-906-3 |
ACRIDINE ORANGE
|
65-61-2 |
3,6-双(二甲基氨基)吖啶
|
3,6-双(二甲基氨基)吖啶;3,6-双(二甲氨基)吖啶盐酸盐;吖啶橙盐酸盐;盐酸吖啶橙;盐酸吖啶橙水合80%;盐酸吖啶橙水合显微镜用;吖啶盐酸盐(>98%,BS);吖啶橙,盐酸盐水合物
|
C17H20ClN3 |
301.81 | 200-614-0 |
BRD7116
|
329059-55-4 |
BRD7116
|
BRD7116;BRD-7116;BRD 7116;BRD-7116;BRD 7116
|
C28H36N2O4S |
496.66144 | |
KC7F2
|
927822-86-4 |
KC7F2
|
KC7F2, >98%;N,N'-(Dithiodi-2,1-ethanediyl)bis[2,5-dichloro-benzenesulfonaMide;KC7F2;N,N'-(2,2'-disulfanediylbis(ethane-2,1-diyl))bis(2,5-dichlorobenzenesulfonamide);N,N'-(Disulfanediylbis(ethane-2,1-diyl))bis(2,5-dichlorobenzenesulfonamide);HIF-1α Translation Inhibitor, KC7F2;2,5-dichloro-N-[2-[2-[(2,5-dichlorophenyl)sulfonylamino]ethyldisulfanyl]ethyl]benzenesulfonamide;HIF-1α Translation Inhibitor, KC7F2 - CAS 927822-86-4 - Calbiochem
|
|||
MSDC-0160
|
146062-49-9 |
MSDC-16
|
CAY10415;CAY-10415;CAY 10415;MSDC 0160;MSDC0160;MITOGLITAZONE;CAY10415;MSDC 0160;CS-1615;MSDC-0160
|
C19 H18 N2 O4 S |
370.43 | |
GSK2830371
|
1404456-53-6 |
GSK 283371
|
|
C23H29ClN4O2S |
461.01996 | |
PIPERLONGUMINE
|
20069-09-4 |
荜茇酰胺
|
PIPERLONGUMINE 荜茇酰胺;荜茇酰胺;(E)-1-(3-(3,4,5-TRIMETHOXYPHENYL)ACRYLOYL)PIPERIDIN-2-ONE;3,5-三甲氧基肉桂酰环己酰胺(荜芨酰胺);荜拨明宁碱
|
C17H19NO5 |
317.34 | 812-597-2 |
Honokiol
|
35354-74-6 |
和厚朴酚
|
和厚朴酚,≥98% ;NSC 293100;NSC293100;NSC-293100;超临界萃取厚朴提取物;3’,5-二-2-丙烯基-1,1’-联苯-2,4’-二酚;和厚朴酚;和厚朴酚HPLC检测纯度为98%;3',1'-联苯-2,4'-二酚,和厚朴酚;厚朴酚和厚朴酚标准品
|
C18H18O2 |
266.33 | 609-119-8 |
Ellipticine
|
519-23-3 |
椭圆玫瑰树碱
|
椭圆玫瑰树碱溶液;椭圆玫瑰树碱;CCG-36483;CCG36483;CCG 36483;BRN-0221300;BRN0221300;BRN 0221300;DB-052047;K00071;LP00531;LS-133282;NSC 71795;NSC71795;NSC-71795;TCMDC-125546;VZ29809. ELLIPTECINE;ELLIPTICINE;ELLIPTISINE;玫瑰树碱;椭圆玫瑰树碱溶液;5,11-二甲基-6H-吡啶并[4,3-B]咔唑
|
C17H14N2 |
246.31 | 208-264-0 |
5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide hydrochloride
|
158681-13-1 |
盐酸利莫那班
|
CS-1821;盐酸利莫那班;5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-N-(1-哌啶基)-1H-吡唑-3-甲酰胺盐酸盐;5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-N-(1-哌啶基)-1H-吡唑-3-甲酰胺单盐酸盐;利莫那班盐酸盐;N-(哌啶-1-基)-5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-1H-吡唑-3-甲酰胺盐酸盐;SR 141716A; SR 151716A;利莫那班D10盐酸
|
C22H21Cl3N4O.ClH |
500.25 | 213-485-0 |